Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Specialized medicine - private practice in ქ. ბათუმი, აჭარა. Address: საქართველო, ქ. ბათუმი, ლეხ და მარია კაჩინსკების ქ., N 1ა, სართული5, სადარბაზო D, ბ. D405.
GCAP internal — Sectors and enrichment.xlsx (2026-06-10)
| Ratio | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | -7.1% | 23.6% | 6.8% | 53.4% |
| EBITDA Margin | -198.5% | 3.0% | -30.6% | -6.5% |
| EBITDAR | -538 | 77 | -190 | -53 |
| EBITDAR Margin | -198.5% | 3.0% | -30.6% | -6.5% |
| EBIT Margin | -198.5% | 2.9% | -68.6% | -36.2% |
| Net Profit Margin | -199.9% | 2.6% | -83.4% | -37.1% |
| Operating Expense % of Sales | 191.5% | 20.6% | 37.4% | 59.9% |
| Returns | ||||
| Return on Assets (ROA) | -9.2% | 1.1% | -9.0% | -5.4% |
| Return on Equity (ROE) | -11.2% | 1.4% | -9.7% | -5.9% |
| ROIC [EBIT / Invested Capital] | -11.0% | 1.6% | -8.1% | -5.8% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 0.9% | 0.0% | 1.9% | 3.0% |
| Debt-to-Equity | 0.01x | 0.00x | 0.02x | 0.03x |
| Debt-to-EBITDA | N/A | 0.00x | N/A | N/A |
| Equity-to-Assets | 82.1% | 79.8% | 92.5% | 90.6% |
| Net Debt | 51 | -240 | -73 | -49 |
| Cash & Equivalents | 4 | 240 | 180 | 215 |
| Total Debt | 55 | N/A | 107 | 166 |
| Liquidity & working capital | ||||
| Current Ratio | 0.12x | 0.45x | 0.90x | 0.81x |
| Quick Ratio | 0.08x | 0.32x | 0.90x | 0.81x |
| Cash Ratio | 0.00x | 0.19x | 0.41x | 0.41x |
| Total Current Assets | 121 | 563 | 393 | 426 |
| Total Current Liabilities | 1,051 | 1,239 | 435 | 526 |
| Inventory | 40 | 163 | N/A | N/A |
| Trade Receivables | 77 | 160 | 103 | 59 |
| Trade Payables | 167 | 289 | 297 | 303 |
| Net Working Capital | -930 | -676 | -42 | -100 |
| Net Working Capital % of Revenue | -343.0% | -25.8% | -6.8% | -12.5% |
| Trade Working Capital | -50 | 34 | -194 | -244 |
| Trade Working Capital % of Revenue | -18.4% | 1.3% | -31.3% | -30.4% |
| Change in Trade Working Capital | N/A | 84 | -228 | -50 |
| Turnover & efficiency | ||||
| Inventory Turnover | 7.18x | 12.27x | N/A | N/A |
| Days Inventory Outstanding (DIO) | 50.8 | 29.7 | N/A | N/A |
| Receivables Turnover | 3.54x | 16.30x | 6.05x | 13.69x |
| Days Sales Outstanding (DSO) | 103.1 | 22.4 | 60.3 | 26.7 |
| Payables Turnover | 1.74x | 6.90x | 1.95x | 1.24x |
| Days Payable Outstanding (DPO) | 210.0 | 52.9 | 187.2 | 294.9 |
| Cash Conversion Cycle | -56.1 days | -0.7 days | -126.9 days | -268.3 days |
| Asset Turnover | 0.05x | 0.43x | 0.11x | 0.14x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 2 | 473 | -58 | 31 |
| Free Cash Flow (OCF − Capex proxy) | 19 | 444 | -58 | 31 |
| Cash Conversion (OCF / EBITDA) | N/A | 611.8% | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →